Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences share price trading maginally lower in the opening trade on October 3 despite the company received ...

Pharma stock engaged in manufacturing and distributing of pharmaceutical products gained traction on Thursday’s trading ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, fundraising and ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...

Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose ...

Ahmedabad: Zydus Lifesciences has received the EIR report from the U.S. Food and Drug Administration (USFDA) for the ...

The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

Patients with metastatic castration-sensitive prostate cancer are recommended to be treated with enzalutamide tablets.

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...